Predictive factors of immune tolerance treatment response in severe haemophilia A patients with inhibitors: A real‐world report from a single centre, mixed retrospective‐prospective long‐term study
Open Access
- 3 January 2019
- journal article
- letter
- Published by Wiley in Haemophilia
- Vol. 25 (2) , E97-E100
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction studyHaemophilia, 2015
- Primary and rescue immune tolerance induction in children and adults: a multicentre international study with a VWF‐containing plasma‐derived FVIII concentrateHaemophilia, 2013
- Immune tolerance induction in haemophilia A patients with inhibitors by treatment with recombinant factor VIII: a retrospective non‐interventional studyHaemophilia, 2013
- The principal results of the International Immune Tolerance Study: a randomized dose comparisonBlood, 2012
- International workshop on immune tolerance induction: consensus recommendations1Haemophilia, 2007
- Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor responseHaemophilia, 2007
- Immune tolerance induction with recombinant factor VIII in hemophilia A patients with high responding inhibitors.2006
- Immune tolerance in children with factors VIII and IX inhibitors: a single centre experienceHaemophilia, 2005
- Immune tolerance treatment in haemophilia patients with inhibitors: the Spanish RegistryHaemophilia, 2001
- Immune tolerance therapy in paediatric haemophiliacs with factor VIII inhibitors: 14 years follow‐upHaemophilia, 1995